Home / News / International / USFDA conducts inspection at Biocon’s Bengaluru facility

USFDA conducts inspection at Biocon’s Bengaluru facility

United States Food and Drug Administration (USFDA) has conducted a pre-approval inspection of Biocon’s new Oral Solid Dosage Forms manufacturing facility at Bengaluru from November 05 to 09. The audit concluded without any observations and no Form 483 was issued.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient’s worldwide.

x

Check Also

NASA picks ancient Martian river delta for 2020 rover touchdown

NASA picks ancient Martian river delta for 2020 rover touchdown

NASA has picked an ancient river delta as the landing site for ...

Educational institutions built with Indian assistance inaugurated

Educational institutions built with Indian assistance inaugurated

In Nepal, three educational institutions built with the Indian assistance of 126.60 ...